bioRxiv Science⌕ Search

bioRxiv · 10.1101/2022.03.24.485654

Suboptimal foraging decisions and involvement of the ventral tegmental area in human opioid addiction

Abstract

Addiction is marked by a tendency to exploit sources of reward despite diminishing returns. This behavior is aptly captured by animal patch-foraging models that have recently been extended to humans. Dopamine and norepinephrine centrally mediate addictive behavior and activity in both catecholaminergic systems is proposed to reflect the computations necessary for optimal foraging. However, the specific neural bases of excessive foraging and their role in human addiction are largely unknown. To address this gap, we studied the behavior of people with and without opioid use disorder (OUD) on a patch-foraging task in which they made serial decisions to "harvest" a depleting resource ("patch") for reward or incur a varying cost to "travel" to a replenished patch. In a subset of participants, we used high-resolution neuromelanin-sensitive MRI to image neuromelanin concentration, a proxy for long-term catecholaminergic function, in distinct dopaminergic nuclei (ventral tegmental area, substantia nigra subregions) and the noradrenergic locus coeruleus. While all participants were sensitive to the long-run reward rates of different patch-foraging environments, OUD participants stayed in reward patches longer than optimal--markedly overharvesting a source of reward despite its declining value--and this correlated with more chronic drug use. Overharvesting was selectively associated with lower neuromelanin signal in the ventral tegmental area but not other dopaminergic nuclei, nor the locus coeruleus. Our findings suggest that foraging decisions relevant to addiction involve a ventral-tegmental-area circuit that may signal reward rates in dynamic environments and implicate this circuit in maladaptive reward pursuit in human addiction to opioids. Significance statementPatch-foraging provides a potentially important translational framework for understanding addictive behavior by revealing how maladaptive reward pursuit emerges in more ecologically valid decision contexts. Here, we show that the tendency to exploit sources of reward despite diminishing returns is associated with chronic drug use in people with opioid use disorder, a particularly devastating form of addiction. We further use neuromelanin-sensitive MRI, a neuroimaging measure of the long-term function of dopamine neurons, to reveal that variation in ventral tegmental area neuromelanin signal selectively underlies individual differences in this overharvesting bias. These findings establish a role for specific dopaminergic circuits in patch-foraging decisions and advance understanding of the neurobiology of human addiction to opioids that has so far eluded the field.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Raio, C. M., Biernacki, K., Kapoor, A., Wengler, K., Bonagura, D., Xue, J., Constantino, S. M., Horga, G., Konova, A. B.. 2022-03-27. Suboptimal foraging decisions and involvement of the ventral tegmental area in human opioid addiction. https://doi.org/10.1101/2022.03.24.485654

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗